IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3099 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (1,664 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed2057    
    Printed22    
    Emailed0    
    PDF Downloaded90    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR
Year : 2014  |  Volume : 80  |  Issue : 6  |  Page : 547-549

Multiple cutaneous mastocytomas


1 Departments of Dermatology, Venereology and Leprology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
2 Department of Pathology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India

Date of Web Publication7-Nov-2014

Correspondence Address:
Taru Garg
Department of Dermatology, Venereology and Leprology, Lady Hardinge Medical College and Associated Hospitals, New Delhi - 110 001
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.144189

Rights and Permissions



How to cite this article:
Garg T, Chander R, Gaur N, Singh A, Nangia A. Multiple cutaneous mastocytomas . Indian J Dermatol Venereol Leprol 2014;80:547-9

How to cite this URL:
Garg T, Chander R, Gaur N, Singh A, Nangia A. Multiple cutaneous mastocytomas . Indian J Dermatol Venereol Leprol [serial online] 2014 [cited 2020 Jun 4];80:547-9. Available from: http://www.ijdvl.com/text.asp?2014/80/6/547/144189


Sir,

Cutaneous mastocytosis is defined by abnormal infiltration of mast cells limited to the skin. Urticaria pigmentosa and mastocytoma are the most common clinical types while diffuse cutaneous mastocytosis is a rare entity. Mastocytoma is a solitary nodular lesion which may be present at birth or appears within the first 3 months of life and resolves spontaneously with age. [1]

A 3-month-old boy presented with skin-colored raised lesions, progressively increasing in number and scattered all over the body noted a few hours after birth. He had history of multiple episodes of blistering within these raised skin lesions. There were no systemic complaints. Antenatal, birth and developmental history were normal.

On cutaneous examination, there were 11 discrete, well-defined, nodulo-plaques over face, trunk, and extremities [Figure 1]. A few serous fluid-filled bullae were present on top of the lesions on the back. Darier's sign was positive [Figure 2]a. While the child was being evaluated as an in-patient, he started developing episodes of flushing, which lasted for 3-4 minutes [Figure 2]b. These were not associated with hypotension or tachycardia.The child also developed two new lesions over the scalp.
Figure 1: Multiple nodulo-plaques, also showing bullae, at various sites

Click here to view
Figure 2: (a) Darier's sign. (b) Generalized erythema during an episode of flushing

Click here to view


The histopathological examination of one of the nodules revealed sheets of mast cells in the dermis [Figure 3]a. On toluidine blue staining, intracellular metachromatic granules were seen [Figure 3]b.
Figure 3: (a) Sheets of mast cells in dermis (H and E, ×10), (b) Toludine blue stain showing mast cells with granular cytoplasm (×40)

Click here to view


Hematological parameters were normal except for slightly low hemoglobin (11 gm/dl) and eosinophilia (absolute eosinophil count 500/microliter). His serum biochemistry was normal. Radiological investigations and bone marrow examination were normal.

The parents were advised regarding avoidance of potential triggers of mast cell degranulation. The child was treated with various oral H1 antihistamines (cetirizine, dexchlorpheniramine, promethazine, hydroxyzine). Fluticasone propionate 0.05% ointment application was advised over the nodules. No other drugs were started in view of the age of the child and the doubtful safety profile of mast cell stabilizers in children less than 2 years of age. The episodes of flushing became infrequent, no new lesions appeared, and there was some flattening of skin lesions after 3 months. Subsequently, the child was lost to follow-up.

A majority (65%) of patients with cutaneous mastocytosis present in childhood, among which, 55% do so before the age of 2. Mastocytomas are present in 10-35%. Most mastocytomas appear during the first year of life with around 42% presenting at birth. Vesiculation and bulla formation are observed in 33% of mastocytomas. [2] Our patient had multiple mastocytomas which is rare. [1]

Flushing occurs in 6.5% of patients and abdominal pain has also been described in cases with mastocytomas. Our patient experienced multiple episodes of flushing which were not associated with hypotension. Systemic symptoms are rare in pediatric cutaneous mastocytosis. These are seen more often in those with extensive skin involvement, episodes of flushing, early onset of disease and bullous lesions. These patients have a potential risk for experiencing shock or sudden death. [3]

Plasma tryptase and histamine concentrations reflect the increased proliferation of mast cells and/or their activation. [4] Bone marrow biopsy in those with childhood-onset cutaneous disease is not recommended unless there is evidence of systemic disease such as unexplained peripheral blood abnormalities, hepatosplenomegaly, and lymphadenopathy. [5] It has been suggested that a serum tryptase level exceeding 100 ng/ml or more is an indication for bone marrow examination regardless of age. [2] Due to monetary constraints, the plasma tryptase levels could not be done in our patient. As he had frequent flushing episodes, appearance of new skin lesions and multiple mastocytomas, bone marrow examination was carried out, which turned out to be normal.

The therapy for mastocytosis is focused on providing symptomatic relief and avoidance of triggering factors. H1 antihistamines control pruritus, flushing and urticaria. In spite of receiving antihistamines, our patient had, an initial, increase in the duration of flushing episodes. We assume that this was because triggering factors like friction could not be avoided due to the multiplicity of lesions.The other reason could be an inadequate dose of antihistamines due to lack of sufficient data on dosage in the very young. Sometimes, flushing can be caused by chemical mediators other than histamine.To add to the problem, the safety profile of drugs with mast cell stabilizing properties like ketotifen and azelastine in infants and the very young has not been established. [6] Surgical excision of solitary mastocytoma, topical calcineurin inhibitors and topical corticosteroids are among the other modalities of treatment.

The course of the disease in children is often benign and there is usually no progression to systemic disease. The occurence of multiple mastocytomas with bullous lesions as a presenting feature is unusual. The control of flushing in such an instance may be difficult. There is need for more therapeutic options and guidelines for the treatment of pediatric mastocytosis, especially in very young infants.

 
  References Top

1.
Lange M, Nedoszytko B, Górska A, Zawrocki A, Sobjanek M, Kozlowski D. Mastocytosis in children and adults: Clinical disease heterogeneity. Arch Med Sci 2012;8:533-41.  Back to cited text no. 1
    
2.
Ben-Amitai D, Metzker A, Cohen HA. Paediatric cutaneous mastocytosis: A review of 180 Patients. Isr Med Assoc J 2005;7:320-2.  Back to cited text no. 2
    
3.
Murphy M, Walsh D, Drumm B, Watson R. Bullous mastocytosis: A fatal outcome. Pediatr Dermatol 1999;16:452-5.  Back to cited text no. 3
    
4.
Schwartz LB, Sakai K, Bradford TR, Ren SL, Zweiman B, Worobec AS, et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-10.  Back to cited text no. 4
    
5.
Kettelhut BV, Metcalfe DD. Plasma histamine concentrations in evaluation of pediatric mastocytosis. J Pediatr 1987;111:419-21.  Back to cited text no. 5
    
6.
Carter MC, Metcalfe DD. Pediatric mastocytosis. Arch Dis Child 2002;86:315-9.  Back to cited text no. 6
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow